TY - JOUR
T1 - Verapamil-Digoxin Interaction
AU - Klein, Herman O.
AU - Lang, Robert
AU - Di Segni, Elio
AU - Kaplinsky, Eliezer
PY - 1980/7/17
Y1 - 1980/7/17
N2 - To the Editor: Dr. Doering wrote in the August 23, 1979, issue that no drug except quinidine influenced the serum levels of digoxin. In Table 1 in his article, specific reference was made to verapamil. Since our experience seems to be different, we think it is important to bring our results to the attention of your readers. In the past five years, we have been treating chronic atrial fibrillation with verapamil to decrease atrioventricular conduction and slow the ventricular rate.* In the course of treating 41 patients, we found that serum digoxin levels increased from 0.96±0.08 to 1.63±0.12 ng per.
AB - To the Editor: Dr. Doering wrote in the August 23, 1979, issue that no drug except quinidine influenced the serum levels of digoxin. In Table 1 in his article, specific reference was made to verapamil. Since our experience seems to be different, we think it is important to bring our results to the attention of your readers. In the past five years, we have been treating chronic atrial fibrillation with verapamil to decrease atrioventricular conduction and slow the ventricular rate.* In the course of treating 41 patients, we found that serum digoxin levels increased from 0.96±0.08 to 1.63±0.12 ng per.
UR - http://www.scopus.com/inward/record.url?scp=0018828328&partnerID=8YFLogxK
U2 - 10.1056/NEJM198007173030316
DO - 10.1056/NEJM198007173030316
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.letter???
C2 - 7383080
AN - SCOPUS:0018828328
SN - 0028-4793
VL - 303
SP - 160
JO - New England Journal of Medicine
JF - New England Journal of Medicine
IS - 3
ER -